Developmental Issues: Physiologic Factors Affecting the Safety and Bioavailability

Nutrition Today
|September 28, 2002
PubMed

Insights

This review covers infant digestive and absorptive development, focusing on premature infants and gut immune function. It examines dietary supplement bioavailability, safety, and recommendations for the first year of life.

Area of Science:

  • Neonatal physiology
  • Gastroenterology
  • Immunology

Background:

  • Infant digestive and absorptive functions undergo significant development from birth through the first year.
  • Premature infants present unique challenges regarding these developing gut functions.
  • The interplay between gut immune function and nutrient bioavailability is crucial for infant development.

Purpose of the Study:

  • To review the developmental trajectory of digestive and absorptive functions in infants.
  • To address specific concerns related to these functions in premature infants.
  • To evaluate the impact of gut immune function on the bioavailability of dietary supplements.

Main Methods:

  • Comprehensive literature review of existing studies on infant gut development.
  • Analysis of data concerning premature infant gastrointestinal function.
  • Examination of research on host immune responses in the developing gut and supplement absorption.

Main Results:

  • Maturation of digestive and absorptive capabilities occurs throughout the first year of life.
  • Prematurity impacts the rate and extent of functional development.
  • Gut immune status influences the efficacy and absorption of dietary supplements.

Conclusions:

  • Understanding infant gut maturation is key to addressing nutritional needs.
  • Premature infants require tailored nutritional and supportive strategies.
  • Optimizing dietary supplement bioavailability necessitates consideration of the developing gut immune system.

Related Concept Videos

Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
Factors Influencing Bioavailability: First-Pass Elimination01:23

Factors Influencing Bioavailability: First-Pass Elimination

When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...